---
title: "Supira Medical to initiate US clinical programme for pVAD system"
date: "2023-11-22T11:21:42.000Z"
publishedDate: "22 novembre 2023"
summary: "Supira Medical announced today that it has received US Food and Drug Administration (FDA) breakthrough device designation for its Supira percutaneous ventricular assist device (pVAD). The approval comes as the company closes US$40M in Series D financing and prepares to initiate its US clinical programme."
importance: ""
sourceUrl: "https://cardiovascularnews.com/supira-medical-to-initiate-us-clinical-programme-for-pvad-system/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-11-22-supira-medical-to-initiate-us-clinical-programme-for-pvad-system"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/Supira_Medical_Physicians-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/supira-medical-to-initiate-us-clinical-programme-for-pvad-system/"
---

![Supira Medical to initiate US clinical programme for pVAD system](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/Supira_Medical_Physicians-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/supira-medical-to-initiate-us-clinical-programme-for-pvad-system/*

## L’essentiel

Supira Medical announced today that it has received US Food and Drug Administration (FDA) breakthrough device designation for its Supira percutaneous ventricular assist device (pVAD). The approval comes as the company closes US$40M in Series D financing and prepares to initiate its US clinical programme.

## Lien source

https://cardiovascularnews.com/supira-medical-to-initiate-us-clinical-programme-for-pvad-system/
